Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
ELTP > SEC Filings for ELTP > Form 8-K on 15-Nov-2012All Recent SEC Filings

Show all filings for ELITE PHARMACEUTICALS INC /NV/

Form 8-K for ELITE PHARMACEUTICALS INC /NV/


15-Nov-2012

Other Events


Item 8.01 Other Events

On November 15, 2012, Elite Pharmaceuticals, Inc. (the "Company") issued a press release to announce the initial shipment of Phendimetrazine tartrate 35 mg tablets under the previously announced manufacturing and supply agreement with Mikah Pharma, LLC ("Mikah"). Actavis, Inc. ("Actavis"), recently acquired by Watson Pharmaceuticals, Inc., will distribute the product as part of a distribution agreement between Mikah and Actavis.

A copy of the press release is being finished with this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference.

  Add ELTP to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ELTP - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.